1. Home
  2. DH vs ESPR Comparison

DH vs ESPR Comparison

Compare DH & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DH
  • ESPR
  • Stock Information
  • Founded
  • DH 2011
  • ESPR 2008
  • Country
  • DH United States
  • ESPR United States
  • Employees
  • DH N/A
  • ESPR N/A
  • Industry
  • DH Computer Software: Prepackaged Software
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DH Technology
  • ESPR Health Care
  • Exchange
  • DH Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • DH 310.5M
  • ESPR 305.0M
  • IPO Year
  • DH 2021
  • ESPR 2013
  • Fundamental
  • Price
  • DH $2.82
  • ESPR $1.67
  • Analyst Decision
  • DH Hold
  • ESPR Buy
  • Analyst Count
  • DH 11
  • ESPR 7
  • Target Price
  • DH $5.35
  • ESPR $6.36
  • AVG Volume (30 Days)
  • DH 1.3M
  • ESPR 4.2M
  • Earning Date
  • DH 05-06-2025
  • ESPR 03-04-2025
  • Dividend Yield
  • DH N/A
  • ESPR N/A
  • EPS Growth
  • DH N/A
  • ESPR N/A
  • EPS
  • DH N/A
  • ESPR N/A
  • Revenue
  • DH $252,202,000.00
  • ESPR $332,314,000.00
  • Revenue This Year
  • DH N/A
  • ESPR $5.51
  • Revenue Next Year
  • DH $3.23
  • ESPR $1.42
  • P/E Ratio
  • DH N/A
  • ESPR N/A
  • Revenue Growth
  • DH 0.31
  • ESPR 185.66
  • 52 Week Low
  • DH $2.55
  • ESPR $1.47
  • 52 Week High
  • DH $8.35
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • DH 31.16
  • ESPR 48.04
  • Support Level
  • DH $2.56
  • ESPR $1.47
  • Resistance Level
  • DH $3.04
  • ESPR $1.61
  • Average True Range (ATR)
  • DH 0.30
  • ESPR 0.13
  • MACD
  • DH -0.02
  • ESPR 0.01
  • Stochastic Oscillator
  • DH 19.57
  • ESPR 51.28

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: